Department of Cardiac Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Cardiovascular Institute, Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, 510080, PR China.
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, 510080, China.
BMC Cardiovasc Disord. 2024 Jul 25;24(1):385. doi: 10.1186/s12872-024-04042-3.
Fontan-associated liver disease (FALD) is one of the most common complications following Fontan procedure, but the impact of FALD on survival outcomes remains controversial. The aim of this systematic review and meta-analysis was to examine and quantify the influence of liver disease on the survival of Fontan patients.
The Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed, and relevant human studies published from inception up to 12 August 2022 were searched. Stata (version 17.0) was applied to perform the meta-analysis, using random effects (Mantel-Haenszel) models. The I statistic was used to assess the heterogeneity. Subgroup analysis and meta-regression were employed to explore the potential sources of heterogeneity and sensitivity analysis was performed to determine the potential influence of each study on the overall pooled results.
A total of 312 records were initially identified and 8 studies involving 2,466 patients were selected for inclusion. Results revealed a significant association between the severity of liver disease following Fontan procedure and mortality, which was confirmed by sensitivity analysis and subgroup analysis assessing post-HT mortality. Meta-regression showed that diagnostic methods for liver disease may be a source of heterogeneity. After removal of the FALD patients identified by international classification of disease codes, heterogeneity was markedly reduced, and the positive association between all-cause mortality and the severity of liver disease became significant.
This meta-analysis showed the severity of liver disease following the Fontan procedure has a significant association with mortality. Lifelong follow-up is necessary and imaging examinations are recommended for routine surveillance of liver disease. Among patients with failing Fontan and advanced liver disease, combined heart-liver transplantation may provide additional survival benefits.
Fontan 相关肝疾病(FALD)是 Fontan 手术后最常见的并发症之一,但 FALD 对生存结果的影响仍存在争议。本系统评价和荟萃分析的目的是检查和量化肝病对 Fontan 患者生存的影响。
本研究遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南,检索了从成立到 2022 年 8 月 12 日发表的相关人类研究。使用 Stata(版本 17.0)进行荟萃分析,采用随机效应(Mantel-Haenszel)模型。采用 I 统计量评估异质性。进行亚组分析和荟萃回归以探讨潜在的异质源,并进行敏感性分析以确定每项研究对总体汇总结果的潜在影响。
共初步确定了 312 条记录,纳入了 8 项研究,共涉及 2466 例患者。结果表明,Fontan 手术后肝脏疾病的严重程度与死亡率之间存在显著关联,这一结果通过敏感性分析和评估 post-HT 死亡率的亚组分析得到了证实。荟萃回归显示,肝脏疾病的诊断方法可能是异质性的一个来源。在排除了通过国际疾病分类代码识别的 FALD 患者后,异质性明显降低,肝脏疾病的严重程度与全因死亡率之间的正相关关系变得显著。
本荟萃分析表明,Fontan 手术后肝脏疾病的严重程度与死亡率显著相关。需要进行终身随访,并建议进行影像学检查以常规监测肝脏疾病。对于 Fontan 衰竭和晚期肝脏疾病的患者,联合心脏-肝脏移植可能提供额外的生存获益。